Reading Time: 8 minutesFollowing on from our previous catch-up blog on clinical management talks presented at the Symposium, here is a continuation that looks at talks focusing on
Search Results for: biomarkers
Reading Time: 3 minutesAt the end of a very busy Day 2 of the Symposium, I sat down with my colleagues for a quick chat. After a while,
Reading Time: 3 minutesWarmest congratulation to Dr Marka van Blitterswijk of the Mayo Clinic in Jacksonville, Florida, winner of this year’s Paulo Gontijo Prize in Medicine. The Award
Causes and disease mechanisms Clinical Trials Markers of Disease Progression MND Research Research we fund
Lighthouse Project shines a beacon on HERVs and their role in ALS
Reading Time: 3 minutesThere is recent evidence to suggest that Human Endogenous Retroviruses (HERVs) may be involved in amyotrophic lateral sclerosis (ALS). HERV-K has been directly linked to
Reading Time: 4 minutesConferences and symposia are a crucial part of the research world – not only for the amount of knowledge that is communicated to large audiences
Reading Time: 5 minutesIt’s been over a month since the announcement by the FDA of their decision to licence edaravone / Radicava for people with MND in the
Reading Time: 3 minutes21 June – MND Awareness Day Each year, the MND Association dedicates the month of June to raising MND awareness. This year, we focus on
Reading Time: 4 minutesBrain banks are a vital resource in MND research. The MRC London Neurodegenerative Diseases Brain Bank was established in 1989. It is part of King’s College
Reading Time: 3 minutesThe AMBRoSIA (A Multicentre Biomarker Resource Strategy In ALS) project is our biggest, most ambitious research undertaking to date. The project funding began in August,